Celularity Inc. (CELU)

Celularity Analyst Ratings

• Total Analysts: 1
• Consensus Rating: Strong Buy
• Price Target: $6.00
• Upside: +368.75%

Ratings History

Filter results

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Steve Brozak WBB Securities	WBB Securities	Hold → Strong Buy Upgrades $6	Hold → Strong Buy	Upgrades	$6	+368.75%	Sep 9, 2025
Steve Brozak WBB Securities	WBB Securities	Buy Initiates $6	Buy	Initiates	$6	+368.75%	Aug 18, 2025
Jeffrey Hung Morgan Stanley	Morgan Stanley	Hold → Sell Downgrades $50 → $10	Hold → Sell	Downgrades	$50 → $10	+681.25%	Jan 30, 2023
Swayampakula Ramakanth HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy Maintains $150 → $25	Strong Buy	Maintains	$150 → $25	+1,853.13%	Jan 30, 2023
Matthew Biegler Oppenheimer	Oppenheimer	Buy → Hold Downgrades n/a	Buy → Hold	Downgrades	n/a	n/a	Dec 22, 2022
Jeffrey Hung Morgan Stanley	Morgan Stanley	Hold Maintains $80 → $50	Hold	Maintains	$80 → $50	+3,806.25%	Sep 12, 2022
James Molloy Alliance Global Partners	Alliance Global Partners	Strong Buy Initiates $150	Strong Buy	Initiates	$150	+11,618.75%	Aug 25, 2022
Asthika Goonewardene Truist Securities	Truist Securities	Hold Maintains $100 → $60	Hold	Maintains	$100 → $60	+4,587.50%	Aug 23, 2022
Swayampakula Ramakanth HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy Initiates $150	Strong Buy	Initiates	$150	+11,618.75%	Jun 22, 2022
Asthika Goonewardene Truist Securities	Truist Securities	Strong Buy → Hold Downgrades n/a	Strong Buy → Hold	Downgrades	n/a	n/a	Apr 6, 2022
Matthew Biegler Oppenheimer	Oppenheimer	Buy Initiates $90	Buy	Initiates	$90	+6,931.25%	Jan 28, 2022
Jeffrey Hung Morgan Stanley	Morgan Stanley	Hold Initiates $90	Hold	Initiates	$90	+6,931.25%	Nov 24, 2021
Asthika Goonewardene Truist Securities	Truist Securities	Strong Buy Initiates $120	Strong Buy	Initiates	$120	+9,275.00%	Oct 19, 2021